Home > National Drug Code (NDC) > Lidocaine Hydrochloride and Dextrose

Lidocaine Hydrochloride and Dextrose - 0338-0411-02 - (Lidocaine Hydrochloride)

Alphabetical Index


Drug Information of Lidocaine Hydrochloride and Dextrose

Product NDC: 0338-0411
Proprietary Name: Lidocaine Hydrochloride and Dextrose
Non Proprietary Name: Lidocaine Hydrochloride
Active Ingredient(s): 8    mg/mL & nbsp;   Lidocaine Hydrochloride
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Lidocaine Hydrochloride and Dextrose

Product NDC: 0338-0411
Labeler Name: Baxter Healthcare Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018461
Marketing Category: NDA
Start Marketing Date: 19810422

Package Information of Lidocaine Hydrochloride and Dextrose

Package NDC: 0338-0411-02
Package Description: 250 mL in 1 BAG (0338-0411-02)

NDC Information of Lidocaine Hydrochloride and Dextrose

NDC Code 0338-0411-02
Proprietary Name Lidocaine Hydrochloride and Dextrose
Package Description 250 mL in 1 BAG (0338-0411-02)
Product NDC 0338-0411
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lidocaine Hydrochloride
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19810422
Marketing Category Name NDA
Labeler Name Baxter Healthcare Corporation
Substance Name LIDOCAINE HYDROCHLORIDE
Strength Number 8
Strength Unit mg/mL
Pharmaceutical Classes Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE]

Complete Information of Lidocaine Hydrochloride and Dextrose


General Information